Primary Health Properties Plc (LON:PHP)

Primary Health Properties Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Primary Health Properties stock has a consensus rating of "Strong Buy" and an average price target of 115p. The average 1-year stock price forecast is 24.25% higher than the current stock price, while the lowest is 105p (+13.88%) and the highest is 128p (+38.83%).

Price Target: 115p (+24.25%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	105p	115p	115p	128p
Change	+13.88%	+24.25%	+24.73%	+38.83%

Analyst Ratings

The average analyst rating for Primary Health Properties stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	Jun '26
Strong Buy	7	6	6	6	6	7
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	8	8	8	8	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Livingston-Booth Kepler Capital	Kepler Capital	Buy Maintains 120p → 115p	Buy	Maintains	120p → 115p	+24.73%	Jun 5, 2026
Mike Prew Jefferies	Jefferies	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Apr 30, 2026
Unknown Analyst Berenberg Bank No rating	Berenberg Bank	Buy Reiterates 128p	Buy	Reiterates	128p	+38.83%	Apr 25, 2026
Kanad Mitra Barclays	Barclays	Buy Maintains 110p	Buy	Maintains	110p	+19.31%	Apr 20, 2026
Unknown Analyst Stifel Nicolaus No rating	Stifel Nicolaus	Buy Reiterates 105p	Buy	Reiterates	105p	+13.88%	Apr 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

334.10M

Increased by 28.50%

from 260.00M

Revenue Next Year

325.16M

Decreased by -2.68%

from 334.10M

EPS This Year

0.07

Increased by 0.90%

from 0.07

EPS Next Year

0.08

Increased by 3.42%

from 0.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	145.60M	154.10M	169.80M	182.00M	260.00M	334.10M
Revenue Growth	4.75%	5.84%	10.19%	7.19%	42.86%	28.50%
Net Income	140.10M	56.30M	27.30M	41.00M	119.00M	248.04M
EPS	-	-	-	-	0.07	0.07
EPS Growth	-	-	-	-	8.96%	0.90%
Dividend / Share	0.06	0.07	0.07	0.07	0.07	0.07
Dividend Growth	-	4.84%	3.08%	2.99%	2.90%	3.03%
Free Cash Flow	60.88M	51.08M	50.85M	54.45M	145.63M	65.00M
FFO / Share	-	-	-	-	-	0.07
P/FFO	-	-	-	-	-	12.51
No. Analysts	-	-	-	-	-	8

EPS based on non-GAAP adjusted numbers. Financial currency is GBP.

Revenue Forecast

Revenue	2026	2027	2028
High	370.9M
Avg	334.1M
Low	314.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	42.7%
Avg	28.5%
Low	21.0%

EPS Forecast

EPS	2026	2027	2028
High	0.08
Avg	0.07
Low	0.07

EPS Growth

EPS Growth	2026	2027	2028
High	2.7%
Avg	0.9%
Low	-4.7%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Jun 5, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Data Sources Report a data error